BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30094884)

  • 1. Successful laparotomy tumor resection and levonorgestrel-releasing intrauterine system for atypical polypoid adenomyoma.
    Narumi R; Takei Y; Morisawa H; Taneichi A; Matsubara S; Fujiwara H
    J Obstet Gynaecol Res; 2019 Jan; 45(1):230-234. PubMed ID: 30094884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alleviation of Symptoms and Improvement of Endometrial Receptivity Following Laparoscopic Adenomyoma Excision and Secondary Therapy with the Levonorgestrel-releasing Intrauterine System.
    Wu Q; Lian Y; Chen L; Yu Y; Lin T
    Reprod Sci; 2020 Jun; 27(6):1259-1265. PubMed ID: 32046429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative maintenance levonorgestrel-releasing intrauterine system for symptomatic uterine adenomyoma.
    Lin CJ; Hsu TF; Chang YH; Huang BS; Jiang LY; Wang PH; Chen YJ
    Taiwan J Obstet Gynecol; 2018 Feb; 57(1):47-51. PubMed ID: 29458902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of levonorgestrel-releasing intrauterine system in early pregnancy: a case report].
    Gardyszewska A; Czajkowski K
    Ginekol Pol; 2012 Dec; 83(12):950-2. PubMed ID: 23488301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.
    Sturridge F; Guillebaud J
    Drug Saf; 1996 Dec; 15(6):430-40. PubMed ID: 8968696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the efficacy of diegnogest and levonorgestrel-releasing intrauterine system after laparoscopic surgery for endometriosis.
    Lee KH; Jung YW; Song SY; Kang BH; Yang JB; Ko YB; Lee M; Han HY; Yoo HJ
    J Obstet Gynaecol Res; 2018 Sep; 44(9):1779-1786. PubMed ID: 29974633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why perimenopausal women should consider to use a levonorgestrel intrauterine system.
    Wildemeersch D
    Gynecol Endocrinol; 2016 Aug; 32(8):659-661. PubMed ID: 26930021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
    Chin J; Konje JC; Hickey M
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007245. PubMed ID: 19821400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Endometrial Hyperplasia With a Levonorgestrel-Releasing Intrauterine System: A Korean Gynecologic-Oncology Group Study.
    Kim MK; Seong SJ; Kim JW; Jeon S; Choi HS; Lee IH; Lee JH; Ju W; Song ES; Park H; Ryu HS; Lee C; Kang SB
    Int J Gynecol Cancer; 2016 May; 26(4):711-5. PubMed ID: 26905333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progestin-releasing intrauterine systems and leiomyoma.
    Kaunitz AM
    Contraception; 2007 Jun; 75(6 Suppl):S130-3. PubMed ID: 17531604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levonorgestrel-releasing intrauterine system vs. transcervical endometrial resection for dysfunctional uterine bleeding.
    Gupta B; Mittal S; Misra R; Deka D; Dadhwal V
    Int J Gynaecol Obstet; 2006 Dec; 95(3):261-6. PubMed ID: 16999960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised clinical trial to assess satisfaction with the levonorgestrel- releasing intrauterine system inserted at caesarean section compared to postpartum placement.
    Braniff K; Gomez E; Muller R
    Aust N Z J Obstet Gynaecol; 2015 Jun; 55(3):279-83. PubMed ID: 26053465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study.
    Varma R; Soneja H; Bhatia K; Ganesan R; Rollason T; Clark TJ; Gupta JK
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):169-75. PubMed ID: 18440693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience with the levonorgestrel-releasing intrauterine system among HIV-infected women.
    Lehtovirta P; Paavonen J; Heikinheimo O
    Contraception; 2007 Jan; 75(1):37-9. PubMed ID: 17161122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levonorgestrel-releasing intrauterine system (LNG-IUS 12) for prevention of pregnancy for up to five years.
    Nelson AL
    Expert Rev Clin Pharmacol; 2017 Aug; 10(8):833-842. PubMed ID: 28617060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hysteroscopic Transcervical Resection for Atypical Polypoid Adenomyoma of the Uterus: A Valid, Fertility-Preserving Option.
    Chiyoda T; Lin BL; Saotome K; Kiyokawa S; Nakada S
    J Minim Invasive Gynecol; 2018 Jan; 25(1):163-169.e1. PubMed ID: 29038039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hysteroscopic management of endometrial polyps and submucous leiomyomas in women using a levonorgestrel-releasing intrauterine system.
    Kuzel D; Lisa Z; Fanta M; Zizka Z; Boudova B; Cindrova-Davies T; Mara M
    Minim Invasive Ther Allied Technol; 2022 Apr; 31(4):615-619. PubMed ID: 33428484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ectopic pregnancy in the levonorgestrel releasing intrauterinesystem (LNG-IUS) user: atypical presentation.
    Abu JI; Wandless GM; Emembolu JO
    J Obstet Gynaecol; 2002 Sep; 22(5):567-8. PubMed ID: 12521443
    [No Abstract]   [Full Text] [Related]  

  • 20. Two Years Follow-Up of Patients with Abnormal Uterine Bleeding after Insertion of the Levonorgestrel-Releasing Intrauterine System.
    Cim N; Soysal S; Sayan S; Yildizhan B; Karaman E; Cetin O; Tolunay HE; Yildizhan R
    Gynecol Obstet Invest; 2018; 83(6):569-575. PubMed ID: 29223999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.